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Abstract
Objective: To determine if older women with both heart disease and diabetes experience worse physical and
psychosocial functioning and higher symptom burden over an 18-month period compared with those with heart
disease alone.
Methods: Data from older women with heart disease (60 years, n¼ 1008, 18% with diabetes) were used to
assess the impact of diabetes on physical functioning (Sickness Impact Profile [SIP]-Physical and Six-Minute
Walk test [6MWT]), psychosocial functioning (SIP-Psychosocial and depressive symptoms), and physical
symptom burden (cardiac and general) at baseline and 4, 12, and 18 months later. Generalized estimating
equation models compared trends in outcomes over time between groups with and without diabetes.
Results: Across all four time points, women with heart disease and diabetes had greater functional impairment,
as indicated by higher SIP scores, than those without diabetes (43%–71% higher SIP-Physical scores and 32%–
65% higher SIP-Pyschosocial scores; all p 0.002). 6MWT distance was 17%–30% less in the diabetes group
across time points (all p 0.002). Depressive symptoms were 27%–39% higher in the diabetes group (all p< 0.03)
except at month 4. Women with diabetes scored 15%–29% higher on a physical symptom index across time
points (all p< 0.05) than those without diabetes; no significant differences were observed in cardiac symptoms
until month 18 (diabetes group 29% higher, p¼ 0.02). Subgroups with and without diabetes in this sample
experienced significantly different trends over time in SIP-Physical scores ( p¼ 0.02) and 6MWT distance
( p¼ 0.05), such that the disadvantage of the diabetes group at baseline was greater 18 months later.
Conclusions: Women with comorbid diabetes and heart disease are vulnerable to poor health-related quality of
life, particularly in terms of physical functioning and symptoms, and require special efforts from clinical care
providers to ameliorate a potential downward trend in these outcomes over time.
Introduction
The well-documented increase in the prevalence oftype 2 diabetes is concurrent with a rise in the number of
people who have cardiovascular disease (CVD), that is, heart
disease or cerebrovascular disease, along with diabetes.1
In 2007, nearly one third of people with diabetes> age 35
reported a cardiovascular condition.2 Even after accounting
for the metabolic syndrome factors that often accompany
diabetes—dyslipidemia, hypertension, and central obesity—
diabetes remains an independent risk factor for CVD.1–3
Although the presence of diabetes more than doubles the
risk of developing CVD for both women and men, the excess
risk is greater for women,4 and the relative risk of diabetes-
associated mortality from coronary heart disease (CHD), the
most common type of CVD, is 50% higher in women than in
men.5 Women with diabetes and CHD or other heart-related
disease may also be particularly vulnerable to impaired
health-related quality of life (HRQL) for two reasons. First,
decrements in physical and psychosocial functioning associ-
atedwith diabetes and heart disease separately are oftenmore
pronounced inwomen than inmen. A number of studies have
shown that women with diabetes or heart disease have worse
physical, mental, and social well-being than their male
counterparts with these disorders.6–10 Second, accumulating
evidence supports the notion of an interactive, negative
influence of heart disease and diabetes on measures of HRQL
and various domains of functioning.11–14
Most prior work on the effects of comorbid diabetes and
heart disease onHRQL is cross-sectional in nature and has not
assessed change over time in HRQL-related outcomes among
people with these two conditions. In addition, the physical
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symptom burden, an important determinant of HRQL, of this
group has not been examined. Finally, although women with
diabetes and heart disease separately tend to have worse
HRQL than men, only one identified study reported gender-
specific data on HRQL among individuals with both disor-
ders; in this study, womenwith CHD and diabetes were more
likely than their male counterparts to have at least 2 weeks of
physically unhealthy days=month.12
Given the growing number of women carrying the double
burden of diabetes and heart disease, researchers and clini-
cians could benefit from more specific knowledge about how
this group’s functioning and symptom burden change over
time. To this end, the current study makes use of longitudinal
data from a large sample of women aged60 with physician-
diagnosed heart disease, almost one fifth of whom also report
diabetes. We tested the hypothesis that women with co-
morbid diabetes and heart disease have worse physical and
psychosocial functioning and greater physical symptom
burden at each of four study time points than do their coun-
terparts without diabetes. Additionally, given that the pres-
ence of diabetes is associated with greater mortality risk
among female CHD patients,15 which implies a pattern of
more steeply declining health in this group, we hypothesized
that thewomen in our samplewith diabetes would experience
a greater decline in HRQL outcomes over an 18-month period
than women without diabetes. To our knowledge, this is the
first study to investigate the long-term trajectory of health
status among women contending with both heart disease and
diabetes.
Materials and Methods
The study sample is from a randomized controlled trial
(RCT) of a heart diseasemanagement intervention tailored for
older women. This intervention, Women take PRIDE, in-
structed participants in the use of behavioral self-regulation
techniques as ameans ofmaking healthy lifestyle changes and
reaching personal disease-management goals. The program
included six units that were offered in either a group or a self-
directed (at-home) format and covered such topics as medi-
cations, diet, physical activity, and stress management. All
program content was tailored to the unique context—roles,
responsibilities, and settings—in which women manage their
heart disease. Prior publications provide additional details on
study design and outcomes of this trial.16–18 All participants
were community-dwelling women 60 years of age treated
by daily heart medication for a cardiovascular condition (i.e.,
arrhythmia, angina, myocardial infarction [MI], congestive
heart failure [CHF], or valvular disease). Names of potential
study participants were generated from patient rosters at
clinics in three urban areas in Michigan. A total of 1128 wo-
men were enrolled at baseline. Study procedures were ap-
proved by the University of Michigan Institutional Review
Board, and informed consent was provided by all partici-
pants. Survey data were collected via telephone interviews at
baseline and at 4, 12, and 18 months later. Research nurses
followed a detailed protocol to obtain clinical measurements
at participating hospitals at each time point.
Measures
Diabetes status. Respondents were classified as having
diabetes (1) if at baseline they indicated that another health
condition besides heart disease was their primary health
problem and named diabetes as this condition or (2) if they
reported having diabetes when asked about other important
health conditions besides heart disease.
Physical functioning. The Sickness Impact Profile (SIP)19
is a 136-item functional health statusmeasure and is one of the
most commonly used indicators of quality of life in heart
disease patients.20 The SIP-Physical dimension score includes
three subscales: ambulation, mobility, and body care and
movement. Scores are derived by adding the values for the
items using predetermined weights for each item within that
category and dividing the sum by the maximum possible
dysfunction score for that dimension or category. This yields a
mean percentage score for each individual, with possible
scores ranging from 0 to 100 and higher scores representing
greater dysfunction or impairment because of health.
The Six-Minute Walk test (6MWT)21 (see reference 22 for a
recent comprehensive review of methodological and clinical
issues pertaining to this measure) is an objective indicator of
physical functioning often used with chronically ill patients,
including those with heart disease.23 Using a premeasured
distance, participants were instructed towalk from end to end
at their own pace and with stops if needed, covering as much
distance as they could during the allotted 6 minutes. The
distance was recorded in feet by a research nurse. This mea-
sure is highly correlated with gold standard measures of
functional status.24
Psychosocial functioning. An 8-item version of the Center
for Epidemiologic Studies-Depression scale (CES-D)25 was
used to measure depressive symptomatology. Somatic and
cognitive aspects of depression are represented by 4 items each.
Possible scores range from 0 to 24, with a higher score re-
presenting more depressive symptoms. The SIP-Psychosocial
dimension is made up of the following four subscales: social
interaction, alertness behavior, emotional behavior, and
communication. Scores are derived as per SIP-Physical
dimension score.
Physical symptom burden. Physical symptom burden
was indicated by the cardiac (chest pain, shortness of breath,
rapid or irregular heartbeat, waking with chest pain, and
waking with shortness of breath) and the general physical
(nonspecific) (fatigue, dizziness, pain other than chest pain,
and numbness or cramping in legs) subscales of the Symptom
and Health Problem Profile.26 Respondents were asked about
the frequency and bother of each symptom in the last week.
Responses to the item: How much would you say the symp-
tom bothers you? (1¼not at all to 5¼ a lot; 0¼not present) for
each symptom were summed within each subscale.
Covariates
Variables used for sample description or as control vari-
ables in multivariate analyses included age (continuous);
race (white¼ 1, otherwise¼ 0); income (0 20,000=year, 1>
20,000=year); number of nondiabetes comorbidities (a con-
tinuous variable derived from the following open-ended
question at baseline: Has a doctor told you that you have any
other important health problems or conditions? responses
were coded and counted); and number of heart-related
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diagnoses (angina, MI, arrhythmia, hypertension, CHF, val-
vular disorder). Although the larger study for which data
were collected was a randomized trial of a self-management
program, the current study did not involve assessing the ef-
fect of this intervention. As there were no differences in the
proportion of women with diabetes in treatment vs. control
conditions, we combined the groups and controlled for in-
tervention status in multivariate analyses. Because of an in-
novative study design that included two program versions
tested within two study arms—an RCT arm and a choice arm
in which women could choose their program format—a total
of 944 women were enrolled in some version of the in-
tervention before the first follow-up point; only 184 were
assigned to a no-treatment control condition.
Statistical analysis
Analyses were conducted using SAS 9.2 (Cary, NC). In-
itially, descriptive statistics of the demographic and health
attributes of the sample at baseline were computed. To ex-
amine differences in mortality between women with and
without diabetes, Kaplan-Meier estimates were used to derive
survival curves for each group over the 18-month follow-up
period. Cox-regression models controlling for age, race,
income, treatment group, number of heart diagnoses, number
of comorbidities, and intervention group status were used
to calculate an adjusted hazard ratio (HR).
Next, repeated-measures analysis was used to test for mean
differences by diabetes status at each time point (baseline and
4, 12, and 18 months) for the six functional health status and
symptom outcomes, adjusting for other factors that were ex-
pected to influence outcomes: age, race, income, treatment
group, number of heart diagnoses, and number of other
comorbidities. The SIP and symptom scales were log-trans-
formed to normalize their distribution. Generalized estimat-
ing equation (GEE) techniques were used to account for
within-subject correlation. In addition, GEE models were
used to compare linear trends over 18 months in functioning
and symptoms between women with and without diabetes.
These models included the following terms: an indicator of
diabetes status, the main effect of time, an interaction between
time and diabetes status, and covariates as listed. Of primary
interest in this analysis was the interaction of time by disease
status, that is, if trajectories of outcomes over time differed
between women with and without diabetes. For all analyses
involving repeated measures, the subsample of respondents
with baseline data and at least one other time point was used
(n¼ 1008).
Results
Of this sample of women with diagnosed heart disease,
18% (n¼ 207) also reported diabetes. Table 1 reports demo-
graphic and health characteristics for the total sample and by
diabetes status. Women with diabetes compared with those
without were significantly younger (mean 71 vs. 73 years) and
less likely to be white (76% vs. 84%; nearly all nonwhite re-
spondents were African American). Overall, women with
diabetes had a greater number of cardiac-related diagnoses
(2.9 vs. 2.5) but no difference in number of nondiabetes co-
morbidities. Between-group comparisons of unadjusted
study outcomes at baseline revealed that women with dia-
betes had significantly higher SIP-Physical scores than those
without diabetes (13.3 vs. 8.3), indicating greater impairment
due to illness; a shorter 6MWT distance (603 vs. 778 feet);
higher SIP-Psychosocial scores (10.6 vs. 6.7); a greater number
Table 1. Sociodemographic and Health Characteristics of Study Sample at Baseline (n¼ 1128)
Total sample (n¼ 1128) Diabetes present (n¼ 207) No diabetes present (n¼ 921)
Variable Mean (SD) or % (n) Mean (SD) or % (n) Mean (SD) or % (n)
Age in years (range 60–90) 72.5 (6.3) 70.8 (6.1) 72.8 (6.3)***
Education
Less than high school 17.1 (193) 19.8 (41) 16.5 (152)
High school 40.0 (451) 41.1 (85) 39.7 (366)
More than high school 42.9 (484) 39.1 (81) 43.8 (403)
Race (% white) 82.7 (933) 76.3 (158) 84.1 (775)***
Number of nondiabetes comorbidities 1.2 (1.1) 1.1 (1.0) 1.2 (1.0)
Heart-related diagnosis
Angina 36.5 (412) 45.9 (95) 34.4 (317)**
Myocardial infarction 40.3 (455) 49.8 (103) 38.2 (352)**
Arrhythmia 54.7 (617) 49.3 (102) 55.9 (515)
CHF 23.7 (267) 37.7 (78) 20.5 (189)***
Valvular disorder 27.4 (309) 21.3 (44) 28.8 (265)*
Hypertension 72.6 (819) 81.2 (168) 70.7 (651)**
Number of heart-related diagnoses 2.6 (1.3) 2.9 (1.4) 2.5 (1.2)***
Unadjusted baseline values of outcomes
SIP-physical (observed range 0–66) 9.3 (10.1) 13.3 (12.2) 8.3 (9.4)***
Six-Minute Walk distance (ft) (12-2070) 748 (460) 603 (401) 778 (466)***
SIP-psychosocial (0–68) 7.4 (10.3) 10.6 (12.2) 6.7 (9.7)***
Depressive symptoms (0–24) 3.5 (4.3) 4.6 (5.0) 3.3 (4.1)***
Cardiac symptom burden (0–25) 3.4 (4.3) 3.9 (4.5) 3.3 (4.2)
General physical symptom burden (0–20) 5.7 (4.9) 6.5 (5.0) 5.5 (4.8)**
***p< 0.001, **p< 0.01, and *p< 0.05 for difference between diabetes and nondiabetes groups based on independent-samples t test or
chi-square test.
CHF, congestive heart failure; SD, standard deviation; SIP, Sickness Impact Profile.
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of depressive symptoms (4.6 vs. 3.3); and a greater general
physical symptom burden (6.5 vs. 5.5). The difference in car-
diac symptom burden (3.9 vs. 3.3) did not reach significance.
During the study period, 33 women died and 147 with-
drew. A greater proportion of women with diabetes died
compared to those without diabetes (6.3 vs. 2.2%, p¼ 0.004).
Figure 1 shows the Kaplan-Meier survival curves for the di-
abetes and nondiabetes groups. Cox-regression analysis
shows that women with diabetes were 2.3 times more likely
than women without diabetes to die during the 18-month
interval. Of the sociodemographic and health covariates
initially included in these models, only count of heart-related
diagnoseswas significant and included in the finalmodel. The
log-rank test was used to test for differences between diabetes
and nondiabetes groups ( p¼ 0.001). The difference in with-
drawals by diabetes status was not significant. In terms of
study outcomes, women who died had worse baseline SIP-
Physical and SIP-Psychological ( p¼ 0.01) scores, higher
depression scores ( p¼ 0.003), and greater cardiac symptom
burden ( p¼ 0.04) compared with completers. Women who
withdrew hadworse SIP-Physical ( p¼ 0.04), SIP-Psychological
( p¼ 0.001), and depression ( p¼ 0.04) scores than those who
remained in the study.
Table 2 shows the results of the repeated-measures analysis
comparing the means of women with and without diabetes
on outcomes at four time points, adjusted for health and
Month 4survival:
Diabetes:97.1%
Non-diabetes:99.2%
Month 12survival:
Diabetes:94.7%
Non-diabetes:98.3% Month 18survival:
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FIG. 1. Kaplan-Meier survival curves by diabetes status at
4, 12, and 18 months. The Cox-regression model was used to
derive the hazard ratio, adjusting for count of heart-related
diagnoses. The log-rank test was used to test for differences
between diabetes and nondiabetes groups ( p¼ 0.001).
Table 2. Adjusted Means of Functioning Indicators at Baseline and 4, 12, and 18 Months:
Comparison Between Women Heart Disease Patients With and Without Diabetes (n¼ 1008)
Cross-sectional: adjusted means (SE)
Baseline Month 4 Month 12 Month 18
SIP physical (0–100)
Diabetes 12.5 (0.89) 11.0 (0.84) 12.9 (0.95) 13.2 (1.0)
No diabetes 8.3 (0.31) 7.7 (0.33) 7.7 (0.32) 7.7 (0.33)
p value <0.001 <0.001 <0.001 <0.001
Six-Minute Walk (feet)
Diabetes 604.2 (35.3) 672.1 (41.4) 592.0 (40.4) 567.6 (41.2)
No diabetes 787.1 (16.8) 812.7 (19.1) 825.0 (18.4) 809.9 (18.5)
p value <0.001 0.002 <0.001 <0.001
SIP psychosocial (0–100)
Diabetes 9.1 (0.86) 7.5 (0.82) 9.4 (0.93) 9.6 (1.0)
No diabetes 6.5 (0.32) 5.7 (0.36) 5.7 (0.31) 5.9 (0.33)
p value <0.001 0.002 <0.001 <0.001
Depression (0–24)
Diabetes 4.2 (0.35) 3.6 (0.35) 4.3 (0.40) 4.6 (0.42)
No diabetes 3.3 (0.14) 3.2 (0.16) 3.3 (0.17) 3.3 (0.17)
p value 0.02 0.30 0.03 0.004
Cardiac symptoms (0–25)
Diabetes 3.7 (0.34) 2.8 (0.39) 3.3 (0.40) 3.6 (0.37)
No diabetes 3.3 (0.14) 2.9 (0.16) 2.8 (0.15) 2.8 (0.15)
p value 0.27 0.55 0.37 0.02
General physical symptoms (0–20)
Diabetes 6.3 (0.38) 6.2 (0.41) 6.2 (0.41) 6.5 (0.44)
No diabetes 5.5 (0.16) 5.2 (0.18) 5.2 (0.18) 5.1 (0.17)
p value 0.05 0.003 0.003 0.013
Adjusted for count of heart diagnoses, age, baseline comorbidities, income, treatment group status, and race. Includes respondents with
data at baseline and at least one other time point.
All outcomes, except depression and 6MWT, were log-transformed to normalize their distribution. Adjusted means are in original scale for
clearer interpretation, but p values are based on log-transformed variables.
SE, standard error; 6MWT, Six-Minute Walk test.
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demographic characteristics. Women with diabetes reported
significantly worse physical functioning (i.e., shorter 6MWT
distances and higher SIP-Physical scores) than their counter-
parts without diabetes at each time point. Among women
with diabetes, SIP-Physical scores were 51% higher at base-
line, 43% higher at month 4, 68% higher at month 12, and 71%
higher at month 18. (Adjusted means, but not percentage
differences, are shown in Table 2.) The 6MWT distance was
23% less among the diabetes group at baseline, 17% less at
month 4, 28% less at month 12, and 30% less at month 18. For
psychosocial functioning, women with diabetes also reported
significantly greater impairment at each time point as mea-
sured by the SIP-Psychosocial; these scores were 40% higher
at baseline, 32% higher at month 4, 65% higher at month 12,
and 63% higher at month 18. Depression scale scores were
higher in the diabetes group at baseline (27% higher), month
12 (30% higher), and month 18 (39% higher). At every time
point, women with diabetes had significantly greater general
physical symptomburden: 15% higher at baseline, 19% higher
at month 4 and month 12, and 27% higher at month 18.
Women with diabetes had significantly greater cardiac symp-
tom burden (29% greater) than those without atmonth 18 only.
The GEE longitudinal analysis assessed the significance of
differences in trends over time between women with diabetes
and those without. Figure 2 depicts the trajectories of these
two groups for each outcome of interest, adjusting for age,
race, income, baseline count of heart-related diagnoses,
baseline count of comorbidities, and intervention group sta-
tus. These graphs also display the equations for the regression
lines for each group, where the intercept represents the main
effect of diabetes on the outcome at baseline, and the slope
represents the trend over time. The p values displayed within
the graph for each outcome indicate the significance of the
difference in trends over time for the diabetes and non-
diabetes groups (i.e., interaction between time and diabetes
status). The coefficient indicating the presence of a linear trend
in outcomes among the subgroup with diabetes was not sig-
nificant for any outcome. Trend differences (i.e., interactions
between time and group) were significant for SIP-Physical
( p¼ 0.02) (Fig. 2a) and 6MWT ( p¼ 0.05) (Fig. 2b). For these
outcomes, women with heart disease and diabetes began the
study period with worse scores than their counterparts
without diabetes, and the magnitude of this difference
increased over the study period. In terms of covariates, in all
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FIG. 2. Longitudinal effect of dia-
betes over 18 months among women
with heart disease and difference in
trends by diabetes status on func-
tioning and symptom outcomes
(n¼ 1008). All models control for
age, race, income, baseline count of
heart-related diagnoses, baseline
count of comorbidities, and inter-
vention group status. p value is for
the difference in trend between the
diabetes and nondiabetes groups.
SIP, Sickness Impact Profile.
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models, number of heart diagnoses, number of comorbidities,
and income significantly ( p< 0.01) predicted outcomes, as
did age for all models except those with depression and car-
diac symptoms as outcomes. Race was a significant predictor
of 6MWT score. Treatment group status was not a predictor of
any outcome. The effect of diabetes at baseline was significant
( p< 0.01) in all models, except for the depression and car-
diac symptommodels (coefficients of covariates not shown in
Fig. 2).
Discussion
In our sample of older women with diagnosed heart
disease, 18% also reported having diabetes. This may un-
derestimate the actual diabetes prevalence in our sample; a
study of over 30,000 women (mean age 66 years) with CHD
enrolled in 14 international trials showed that 23% had
diabetes.27 As expected, given the excess diabetes burden
among nonwhites, women of color were more likely than
white women to report diabetes. Women with diabetes
were 2.3 times more likely to die during the 18-month study
period. In addition to higher mortality rates, using both
objective (6MWT) and self-report (SIP-Physical) measures,
sample women with the combination of diabetes and heart
disease demonstrated poorer physical functioning than
those without diabetes. Past research has also found an
adverse effect of diabetes on various indicators of self-re-
ported physical functioning in older samples, including
mobility, activities of daily living (ADLs), and instrumental
activities of daily living (IADLs).28–31 Our study reinforces
these findings by adding an objective measure of physical
functioning. Like previous studies, our data suggest that
cardiovascular and unrelated comorbidities, such as arthri-
tis, cannot fully account for the negative effect of diabetes
on functioning. Other factors, not measured in the current
study, are likely to link diabetes to functional impairment,
for example, peripheral neuropathy, visual impairment, and
cognitive decline.28,30
We found evidence of substantial physical impairment
among the group of women with both heart disease and di-
abetes. The unadjusted mean 6MWT distance among women
heart disease patients with diabetes at baseline (603 feet) (data
not shown) compares unfavorably with that of similar-age
samples with mobility limitations (764 feet) and history of
stroke (748 feet).32 In terms of the SIP-Physical score, women
with diabetes at baseline had an unadjusted mean score of
13.3 (data not shown), indicating moderate dysfunction,
whereas themean of 8.4 for womenwithout diabetes suggests
mild dysfunction.33 In contrast, a study of older patients with
diabetes in an outpatient clinic reported a mean SIP-Physical
score of only 5.6.14
Our study also provides evidence that the gap in physical
functioning by diabetes status in this population of older
women with heart disease diverges further over time.
Although a significant linear trend toward decreased func-
tioning was not evident among women with diabetes, this
group tended to walk shorter distances over the 18-month
period, whereas women without diabetes tended to walk
longer distances, such that the between-group difference in
trends was statistically significant. This pattern was mirrored
in the SIP-Physical score, a self-report scale indicating how
women experience health limitations in physical functioning
in daily life (e.g., walking less ormore slowly, staying closer to
home).
The presence of diabetes was associated with worse psy-
chosocial functioning at multiple points, as measured by the
SIP-Psychosocial and an abridged version of the CES-D de-
pression scale, although trends over time in psychosocial
functioning were not significantly different between the two
groups. Other studies have found stronger effects of diabetes
on physical domains compared to psychosocial domains.11,14
Because women with heart disease are already at high risk for
depression and psychosocial impairment, any additional
contribution of diabetes to poor psychosocial health is of
concern. Depression is predictive of poor health-related out-
comes, including mortality, in both diabetes34 and heart dis-
ease8 patients and may also contribute to poor physical
functioning, for example, through reduced motivation to be
physically active.
Throughout the study period, women with diabetes were
more bothered by general physical symptoms (e.g., dizziness,
pain other than chest pain) than women without diabetes.
Although the difference in trends by diabetes status was not
significant for either symptom measure, by month 18, the
general physical symptom burden of women without diabe-
tes had slightly decreased since baseline, whereas that of
women with diabetes had slightly increased. These findings
suggest that general physical symptomsmay play a role in the
physical functioning deficits observed among women with
both heart disease and diabetes, for example, by discouraging
physical activity. It is also notable that physical symptoms
have been shown to predict future hospitalization and mor-
tality, independent of comorbidities, in an older population.35
Although differences by diabetes status in cardiac-specific
symptoms were smaller, women with diabetes nonetheless
had greater cardiac symptom burden by long-term follow-up.
Our findings have important implications for clinicians.
Older women with both diabetes and heart disease, a co-
morbidity for which women of color are at especially high
risk, are vulnerable to poor functioning and HRQL. Such
patients would benefit from special efforts from clinical pro-
viders regarding treatment, counseling, and education in
order to deter or ameliorate a potential downward trend
in functioning and symptom burden over time. Ideally, such
intervention would take place as early in the disease course as
possible, with additional ongoing resources and support
provided as needed.
Available evidence suggests that regular physical activity
can prevent decline in physical functioning among older
adults.36 Therefore, this behavior should be strongly encour-
aged among women with dual heart disease=diabetes mor-
bidity. The importance of physical activity to optimal
management of both diabetes and heart disease is well rec-
ognized, and encouraging exercise is an integral part of both
traditional diabetes self-management interventions and car-
diac rehabilitation programs. Participation rates in these for-
mal programs are low,37,38 however, and gender-based and
race-based disparities have been identified in cardiac reha-
bilitation referrals and participation, such that women, and
especially women of color, are least likely to take part.39
Because women of color are disproportionately affected by
diabetes, which increases the risk of poor functioning and
other adverse health outcomes, eliminating race-based dis-
parities in cardiac rehabilitation rates is one strategy for im-
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proving the functioning of this group. Similarly, older women
with diabetes and heart disease should receive particular
encouragement andmotivation to take part in formal diabetes
education. These programs should maximize participation by
vulnerable groups; for example, they should fit criteria for
being Medicare reimbursable40 and offered at settings, for
example, community-based settings, that are acceptable and
appropriate for the intended target audience. In order to
maximize participation and retention, these programs must
be responsive to the needs of older women and women of
color. The literature offers several examples of tailored dia-
betes management interventions for African American and
older women that have been successful in increasing physical
activity.41,42
Our results suggest the possible value of routine clinical
assessment of functioning as well as physical activity level in
older women who have diabetes=heart disease morbidity.
Encouragement and support for engaging in appropriate
levels of activity should be provided on an ongoing basis. Our
data showed greater physical symptomatology among the
subgroup of women with diabetes. These symptoms may
present barriers to exercise, and patients should receive sup-
port in their management and interpretation. To date, no
studies have been conducted that examine unique barriers to
physical activity among patients with heart disease=diabetes
comorbidity, nor have any interventions been tailored to ad-
dress identified barriers for this group. This represents a po-
tentially fruitful area for additional research and program
development.
Special assistance to help women with comorbid diabetes=
heart disease manage negative psychological states may
also help alleviate their disease burden. Routine screening
for depression in this population and initiation of appropri-
ate treatment are critical. Among both diabetes and heart
disease patients, interventions have been developed to iden-
tify and address depression.43,44 Notably, a new study of a
nurse-managed intervention that addresses depression
along with medical disease control for patients with diabetes
or CHD or both with comorbid depression is currently un-
derway.45
There are a number of limitations to this study. The first
concerns the nature of our data about diabetes status. Parti-
cipants reported having diabetes in an open-ended question
about the presence of other important health conditions be-
sides heart disease. It is likely, therefore, that some of the
women in our nondiabetes group actually had diabetes, a
misclassification that would bias between-group comparisons
to the null, resulting in an underestimate of the differences
between women with and without diabetes. Second, we did
not collect additional data about the diabetes diagnosis, such
as duration, complications, or treatment. Such data may have
been useful in further characterizing the sample, examining
differential outcomes in diabetes subgroups, or explaining
functioning deficits among those with diabetes. Third, we
were not able to directly test an interactive effect of diabetes
and heart disease on our HRQL outcomes, as all respondents
had heart disease at baseline. Future studies should attempt to
quantify the extent to which functioning and symptoms
among older women are impacted by diabetes and heart
disease together compared with each condition separately.
Because all sample members agreed to participate in an RCT
of a disease management intervention study, they may be at a
higher level of functioning than the general population of
older womenwith heart disease or be unrepresentative of this
population in other ways. This is unlikely to bias the com-
parisons between women with and without diabetes within
the sample; however, our results cannot be generalized to a
larger population, and it is possible that they underesti-
mate functional impairment and symptom burden in this
population.
Conclusions
The findings from this study add to a growing body of
research on the effects of specific comorbidities in women
by showing that the combination of diabetes and heart
disease has substantial negative effects on certain aspects
of clinical health status. Implementing treatment plans and
supportive services that address the particular needs of
women who are managing both heart disease and diabetes
may help clinicians to ameliorate negative outcomes for
these patients.
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